OTC derivatives supplement

Global consistency a pipe dream, as national regulators go their own way

isda-ofc

There are increasing signs that the dream of developing a globally consistent set of derivatives and bank capital rules will be just that – a dream. Whether it is the European exemption from the credit valuation adjustment capital charge, various attempts by national supervisors to clamp down on modelling freedoms applied by their banks, or the slow creep of the Dodd-Frank Act beyond the shores of the US, there is growing evidence that regulators will do whatever they think is right for their

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here